
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
        <meta name="author" content="YW Chen">
      
      
        <link rel="canonical" href="https://didiowen.github.io/notes-not-scandal/category/medicine/page/6/">
      
      
        <link rel="prev" href="../../../hiv/">
      
      
        <link rel="next" href="../../../reading/">
      
      
      <link rel="icon" href="../../../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.5.33">
    
    
      
        <title>medicine - Notes Not Scandal</title>
      
    
    
      <link rel="stylesheet" href="../../../../assets/stylesheets/main.3cba04c6.min.css">
      
        
        <link rel="stylesheet" href="../../../../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../../../css/timeago.css">
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    
    <script>__md_scope=new URL("../../../..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#medicine" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../../../.." title="Notes Not Scandal" class="md-header__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Notes Not Scandal
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              medicine
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme="default" data-md-color-primary="pink" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme="slate" data-md-color-primary="pink" data-md-color-accent="blue"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../../../.." title="Notes Not Scandal" class="md-nav__button md-logo" aria-label="Notes Not Scandal" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54Z"/></svg>

    </a>
    Notes Not Scandal
  </label>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../.." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_2" >
        
          
          <label class="md-nav__link" for="__nav_2" id="__nav_2_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Archive
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_2">
            <span class="md-nav__icon md-icon"></span>
            Archive
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../archive/2024/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2024
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../../archive/2023/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    2023
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" checked>
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="0">
            
  
  <span class="md-ellipsis">
    Categories
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            Categories
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../abx/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    abx
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../hiv/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    hiv
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
      
    
  
  
    <li class="md-nav__item">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  <span class="md-ellipsis">
    medicine
  </span>
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="../../" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    medicine
  </span>
  

      </a>
      
        

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#hiv" class="md-nav__link">
    <span class="md-ellipsis">
      HIV長效針劑
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#linezolid" class="md-nav__link">
    <span class="md-ellipsis">
      Linezolid健保給付條件
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#daa" class="md-nav__link">
    <span class="md-ellipsis">
      DAA
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../reading/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    reading
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../taiwanese/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    taiwanese
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../tb/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    tb
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../travelling/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    travelling
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
    
  
  
    <li class="md-nav__item">
      <a href="../../../writing/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    writing
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

  

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#hiv" class="md-nav__link">
    <span class="md-ellipsis">
      HIV長效針劑
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#linezolid" class="md-nav__link">
    <span class="md-ellipsis">
      Linezolid健保給付條件
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#daa" class="md-nav__link">
    <span class="md-ellipsis">
      DAA
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
  <div class="md-content" data-md-component="content">
    <div class="md-content__inner">
      <header class="md-typeset">
        <h1 id="medicine">medicine<a class="headerlink" href="#medicine" title="Permanent link">&para;</a></h1>
      </header>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-08-01 00:00:00">August 1, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../" class="md-meta__link">medicine</a>, 
              <a href="../../../hiv/" class="md-meta__link">hiv</a></li>
        
        
          
          <li class="md-meta__item">
            
              4 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="hiv"><a class="toclink" href="../../../../medicine/hiv-long-acting/">HIV長效針劑</a></h2>
<h3 id="cdc"><a class="toclink" href="../../../../medicine/hiv-long-acting/#cdc">CDC申請條件</a></h3>
<p>（一）18歲以上成人。<br />
（二）近6個月內HIV病毒量&lt;50 copies/mL。<br />
（三）每日口服藥物有困難者，並請敘明理由，如：<br />
1. ﻿﻿吞嚥藥物有困難。<br />
2. ﻿﻿有生理或心理等疾病，不適合每日服藥。<br />
3. ﻿﻿口服藥物產生副作用（如：暈眩、嘔吐等）。<br />
4. 其他<br />
（四）同意配合進行2個月一次的注射。<br />
（五）未感染B型肝炎病毒。<br />
（六）過去無病毒抑制失敗、未對CAB或RPV具有已知或疑似抗藥性。<br />
（七）未使用會與CAB或RPV有明顯藥物交互作用之藥物。<br />
（八）女性未懷孕或未有備孕計畫。<br />
（九）潛伏結核感染（LTBI）檢驗為陰性，或已完成TB/LTBI治療。  </p>
<hr />
<p><img alt="criteria" src="../../assets/images/61f80edbefd2782c97f5ae1d8a3d98be_MD5.jpeg" /><br />
<img alt="ae" src="../../assets/images/32336f2ec353610ec46d1aa41cf6d4cf_MD5.jpeg" /><br />
<img alt="add_criteria" src="../../assets/images/5b8ab8b9f4168d7792ca8a28ebae23a5_MD5.jpeg" />  </p>
<h3 id="general-criteria"><a class="toclink" href="../../../../medicine/hiv-long-acting/#general-criteria">General criteria</a></h3>
<p>To be eligible for cabotegravir-rilpivirine, patients should:  </p>
<ul>
<li>Be virologically suppressed and adherent to a stable oral regimen for at least <mark style="background: #FFB8EBA6;">6 to 12 months</mark>. The majority of data evaluating cabotegravir-rilpivirine comes from persons with stable viral suppression prior to switching to long-acting injectables, as described above. (See 'Reasons for switching ART' above.)  </li>
<li>Have no documented or suspected resistance mutations that affect activity of cabotegravir or rilpivirine; reasons to suspect such resistance include imperfect adherence or virologic failure while taking a non-nucleoside reverse transcriptase inhibitor (NNRTI) or an integrase strand transfer inhibitor (INSTI) in the past. In some studies, baseline rilpivirine proviral resistance mutations were a significant predictor of virologic failure with cabotegravir-rilpivirine.  </li>
<li>Ideally, patients should have no <mark style="background: #FFF3A3A6;">history of virologic failure (even with NNRTI/INSTI regimens)</mark>. However, certain acquired resistance mutations may be acceptable if there are no other good treatment options. Trials generally excluded individuals with any history of virologic failure; the only resistance mutation typically permitted for enrollment in the trials was a <mark style="background: #FFB8EBA6;">K103N mutation</mark> (the NNRTI mutation associated with resistance to efavirenz, which may be acquired at time of HIV acquisition).  </li>
<li>Be able and willing to adhere to clinic visits for IM injections. The injections must be administered by a health care professional; they are not approved for at-home use or self-administration.  </li>
<li>Two-drug regimens, including long-acting injectable therapy, should generally be avoided in patients with <mark style="background: #FFF3A3A6;">chronic hepatitis B virus (HBV) infection</mark>, as such patients should receive a tenofovir-containing ART regimen whenever possible. (See "Treatment of chronic hepatitis B in patients with HIV".)  </li>
</ul>
<h3 id="additional-considerations"><a class="toclink" href="../../../../medicine/hiv-long-acting/#additional-considerations">Additional considerations</a></h3>
<p>When determining if cabotegravir-rilpivirine is a suitable regimen for a patient, we also assess the following factors:  </p>
<h4 id="drug-drug-interactions"><a class="toclink" href="../../../../medicine/hiv-long-acting/#drug-drug-interactions">Drug-drug interactions</a></h4>
<p>There are a few drug-drug interactions that are contraindications to parenteral cabotegravir-rilpivirine. These include <mark style="background: #FFF3A3A6;">rifamycins</mark> (rifampin, rifabutin, rifapentine), certain anticonvulsants (carbamazepine, oxcarbazepine, phenobarbital, phenytoin), St. John's wort, and dexamethasone (if more than a single dose).  </p>
<p>IM cabotegravir-rilpivirine should also be used with caution with drugs known to cause <mark style="background: #FFF3A3A6;">prolonged QT or Torsade de Pointes</mark> or in patients with a history of these conditions.  </p>
<p>Cabotegravir may lead to <mark style="background: #FFF3A3A6;">decreased levels of methadone</mark>. Although use of methadone is not a contraindication to IM cabotegravir-rilpivirine, clinical monitoring is recommended and patients may need adjustment of their methadone dose if withdrawal symptoms occur.  </p>
<p>In persons with mpox, initiation of long-acting cabotegravir-rilpivirine should be avoided during <mark style="background: #FFF3A3A6;">tecovirimat</mark> therapy and for two weeks after the conclusion of tecovirimat.  </p>
<h4 id="buttock-implantsfillers"><a class="toclink" href="../../../../medicine/hiv-long-acting/#buttock-implantsfillers">Buttock implants/fillers</a></h4>
<p>For patients with buttock implants or fillers, the injections may not be an option. The medications are approved only for administration in the gluteal region. Data for injections in the vastus lateralis are anticipated in the future.  </p>
<h4 id="hiv-subtype"><a class="toclink" href="../../../../medicine/hiv-long-acting/#hiv-subtype">HIV subtype</a></h4>
<p>In some studies, there was a higher likelihood of virologic failure in patients with HIV subtype A1 or A6 virus (which most often occurs in Eastern Europe and Central Asia and which has been associated with certain integrase gene polymorphisms). In general, this finding doesn't impact our decision to initiate cabotegravir-rilpivirine since virologic failures were rare in the trials (13 out of 1039 participants) and viral subtypes are usually not known. However, we would discuss the possible increased risk of virologic failure if it is known that a patient has subtype A virus or comes from a region with predominance of subtype A virus (see "Global epidemiology of HIV infection"). Viral subtype may not be known though sometimes is reported as part of a genotype resistance assay so a clinician may be able to confirm this information by reviewing past resistance assay results.  </p>
<h4 id="body-mass-index"><a class="toclink" href="../../../../medicine/hiv-long-acting/#body-mass-index">Body mass index</a></h4>
<p>In one study, body mass index (BMI) above 30 kg/m2 was associated with an increased risk of virologic failure. However, the association of high BMI and virologic failure has not been reproduced. With elevated BMI, we do generally opt for a longer needle for injections and pay extra attention to site of administration. (See 'Dosing and administration' below.)</p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-05-22 00:00:00">May 22, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../" class="md-meta__link">medicine</a>, 
              <a href="../../../abx/" class="md-meta__link">abx</a></li>
        
        
          
          <li class="md-meta__item">
            
              1 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="linezolid"><a class="toclink" href="../../../../medicine/linezolid/">Linezolid健保給付條件</a></h2>
<p>108/4/1<br />
1. 限下列條件之一使用：<br />
    1. 確定或高度懷疑為MRSA 肺炎（痰液培養出MRSA，伴隨全身發炎反應，且CXR 出現新的浸潤或痰液性狀改變或氧氣需求增加），並符合下列危險因子之一：（105/2/1、108/4/1）<br />
        1. 65歲以上。<br />
        2. BMI≧30。<br />
        3. 急性腎衰竭、腎功能不穩定時。<br />
        4. 過去90天內曾使用glycopeptides 者。（108/4/1）<br />
    2. 因嚴重肺炎致呼吸衰竭或合併嚴重敗血症之患者，同時有其他部位懷疑或證實為MRSA 感染，得以經驗性使用；惟後續呼吸道微生物學檢查結果無MRSA呼吸道感染證據時，應停止使用。（108/4/1）<br />
    3. 證實為MRSA 複雜性皮膚和皮膚構造感染，並符合下列條件之一：（108/4/1）<br />
        1. 有全身性感染徵兆且白血球數異常（&gt;12,000或&lt;4,000 cells/mcL）。<br />
        2. 免疫功能不全。<br />
    4. 證實為VRE（vancomycin-resistant enterococci)感染，且其VRE 菌株對ampicillin 為抗藥者。（108/4/1）<br />
    5. 其他抗藥性革蘭氏陽性球菌感染，因病情需要，經感染症專科醫師會診確認需要使用者。<br />
2. 心內膜炎（endocarditis）病患不建議使用。（108/4/1）<br />
3. 申報費用時需檢附會診紀錄或相關之病歷資料。</p>
    
  </div>
</article>
      
        <article class="md-post md-post--excerpt">
  <header class="md-post__header">
    
    <div class="md-post__meta md-meta">
      <ul class="md-meta__list">
        <li class="md-meta__item">
          <time datetime="2024-04-18 00:00:00">April 18, 2024</time></li>
        
          <li class="md-meta__item">
            in
            
              <a href="../../" class="md-meta__link">medicine</a></li>
        
        
          
          <li class="md-meta__item">
            
              3 min read
            
          </li>
        
      </ul>
      
    </div>
  </header>
  <div class="md-post__content md-typeset">
    <h2 id="daa"><a class="toclink" href="../../../../medicine/daa/">DAA</a></h2>
<h3 id="glecaprevirpibrentasvir-maviret"><a class="toclink" href="../../../../medicine/daa/#glecaprevirpibrentasvir-maviret">Glecaprevir/pibrentasvir (Maviret)</a></h3>
<ul>
<li>3# QD WM，Child-Pugh B/C不可使用，腎功能不佳可使用  </li>
<li>限使用於 HCV RNA 為陽性及無肝功能代償不全之病毒基因型第 1 型、第 2 型、第 3 型、第 4 型、第 5 型或第 6 型 12 歲（含）以上病患  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>未曾接受治療之患者，給付 8 週  </li>
<li>曾接受含 (peg)interferon 及 ribavirin 及合併或不合併 sofosbuvir 治療組合之患者  <ol>
<li>基因型第 1 、 2 、 4 、 5 或 6 型：  <ol>
<li>無肝硬化者，給付 8 週  </li>
<li>具代償性肝硬化 (Child Pugh score A) 者，給付 12 週  </li>
</ol>
</li>
<li>基因型第 3 型，且無肝硬化或具代償性肝硬化 (Child Pugh score A) 者，給付16 週  </li>
</ol>
</li>
<li>曾接受含 NS5A 抑制劑或 NS3/4A 蛋白酶抑制劑治療之基因型第 1 型患者：  <ol>
<li>若曾接受 NS3/4A 蛋白酶抑制劑治療，但未曾接受 NS5A 抑制劑治療者，給付12 週  </li>
<li>若曾接受 NS5A 抑制劑治療，但未曾接受 NS3/4A 蛋白酶抑制劑治療者，給付16 週  </li>
</ol>
</li>
</ol>
</li>
</ul>
<hr />
<h3 id="sofosbuvirvelpatasvir-epclusa"><a class="toclink" href="../../../../medicine/daa/#sofosbuvirvelpatasvir-epclusa">Sofosbuvir/velpatasvir (Epclusa)</a></h3>
<ul>
<li>1# QD，Child-Pugh B/C可使用，Ccr &lt; 30不建議使用  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>未曾接受或曾接受全口服直接抗病毒藥物 (direct acting anti viral, DAAs) 治療，未併有或併有代償性肝硬化 (Child Pugh score A) 者，給付 12 週  </li>
<li>未曾接受或曾接受 DAAs 治療，併有失代償性肝硬化 (Child Pugh score B 或 C) 者，需合併 ribavirin 治療，給付 12 週  </li>
</ol>
</li>
<li>限未曾申請給付其他同DAAs且不得併用其他 DAAs ，惟若符合下列情形之一者，可再治療一次（一個療程）  <ol>
<li>接受本項藥品或其他 DAAs 第一次治療時中斷療程，且中斷原因屬專業醫療評估必須停藥者  </li>
<li>接受本項藥品或其他 DAAs 第一次治療結束後第 12 週 ，血中偵測不到病毒，目前血中又再次偵測到病毒者  </li>
<li>接受未含 NS5A 抑制劑之 DAAs 第一次治療，於治療完成時或治療結束後第 12 週，血中仍偵測到病毒者，或治療 4 週後之病毒量未能下降超過二個對數值（即下降未達100 倍發生在108年1月1日前）  </li>
</ol>
</li>
</ul>
<h3 id="sofosbuvirvelpatasvirvoxilaprevir-vosevi"><a class="toclink" href="../../../../medicine/daa/#sofosbuvirvelpatasvirvoxilaprevir-vosevi">Sofosbuvir/velpatasvir/voxilaprevir (Vosevi)</a></h3>
<ul>
<li>限使用於HCV RNA為陽性，且未併有肝硬化或併有代償性肝硬化（ Child Pugh A 級）之病毒基因型第 1 型、第 2 型、第 3 型、第 4 型、第 5 型或第 6 型病患  </li>
<li>給付療程如下，醫師每次開藥以 4 週為限  <ol>
<li>基因型 1 、 2 、 3 、 4 、 5 、 6 ，且曾接受含 NS5A 抑制劑治療失敗者，給付 12 週  </li>
<li>基因型 1a 或 3 ，且曾經接受含 sofosbuvir 但無 NS5A 抑制劑治療失敗者，給付 12週  </li>
</ol>
</li>
<li>限未曾申請給付本藥品且曾接受其他全口服直接抗病毒藥物（ direct acting anti viral, DAAs ）第一次治療並符合下列情形之一者  <ol>
<li>接受第一次治療時中斷療程，且中斷原因屬專業醫療評估必須停藥者。  </li>
<li>接受第一次治療完成時或治療結束後第 12 週，血中仍偵測到病毒者，或治療 4 週後之病毒量未能下降超過二個對數值（即下降未達 100 倍）發生在 108 年 1 月 1日前者  </li>
</ol>
</li>
</ul>
<h2 id="recommendations-for-retreatment-of-hepatitis-c-virusinfected-adults-by-prior-exposure"><a class="toclink" href="../../../../medicine/daa/#recommendations-for-retreatment-of-hepatitis-c-virusinfected-adults-by-prior-exposure">Recommendations for Retreatment of Hepatitis C Virus–Infected Adults by Prior Exposure</a></h2>
<table>
<thead>
<tr>
<th>Regimen</th>
<th>Genotype</th>
<th>Classification</th>
<th>Duration</th>
<th>Rating</th>
<th>Caveats and Other Considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sofosbuvir-based treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir</td>
<td>1–6</td>
<td>Recommended</td>
<td>12 wk</td>
<td>I, A</td>
<td>For genotype 3 infection with compensated cirrhosis, add weight-based ribavirin if there are no contraindications.</td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir</td>
<td>1, 2, 4, 5, 6</td>
<td>Alternative</td>
<td>16 wk</td>
<td>I, A</td>
<td>Not recommended for patients with prior exposure to an NS5A inhibitor plus NS3/4A protease inhibitor regimen (eg, elbasvir/grazoprevir).</td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir + sofosbuvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>16 wk</td>
<td>IIa, B</td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir</td>
<td>1–6</td>
<td>Recommended</td>
<td>12 wk</td>
<td>IIa, B</td>
<td>For patients with compensated cirrhosis, addition of weight-based ribavirin is recommended (rating IIa, C).</td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir or sofosbuvir + glecaprevir/pibrentasvir treatment failure without cirrhosis or with compensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Glecaprevir/pibrentasvir + sofosbuvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>16 wk</td>
<td>IIa, B</td>
<td>Extension to 24 wk should be considered in extremely difficult cases (eg, genotype 3 infection with compensated cirrhosis) or failure following sofosbuvir + glecaprevir/pibrentasvir therapy.</td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir/voxilaprevir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>IIa, B</td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir- or NS5A inhibitor–based treatment failure with decompensated cirrhosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Sofosbuvir/velpatasvir + weight-based ribavirin</td>
<td>1–6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>II, Ca</td>
<td>Low initial dose of ribavirin (600 mg) is recommended for patients with CTP class C cirrhosis; increase as tolerated.</td>
</tr>
<tr>
<td>Ledipasvir/sofosbuvir + weight-based ribavirin</td>
<td>1, 4, 5, 6</td>
<td>Recommended</td>
<td>24 wk</td>
<td>II, Cb</td>
<td>Low initial dose of ribavirin (600 mg) is recommended for patients with CTP class C cirrhosis; increase as tolerated.</td>
</tr>
</tbody>
</table>
<p>Abbreviations: CTP, Child–Turcotte–Pugh score; NS3/4A, hepatitis C virus nonstructural protein 3–4A; NS5A, hepatitis C virus nonstructural protein 5A.<br />
<sup>a</sup> Only available data for genotypes 5 or 6 infection are in a small number of persons with compensated cirrhosis.<br />
<sup>b</sup> Only available data for genotype 6 infection are in persons with compensated cirrhosis.</p>
    
  </div>
</article>
      
      
        
          



<nav class="md-pagination">
  <a class="md-pagination__link" href="../../">1</a> <span class="md-pagination__dots">..</span> <a class="md-pagination__link" href="../4/">4</a> <a class="md-pagination__link" href="../5/">5</a> <span class="md-pagination__current">6</span> <a class="md-pagination__link" href="../7/">7</a>
</nav>
        
      
    </div>
  </div>

          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
    
      
      <nav class="md-footer__inner md-grid" aria-label="Footer" >
        
          
          <a href="../../../hiv/" class="md-footer__link md-footer__link--prev" aria-label="Previous: hiv">
            <div class="md-footer__button md-icon">
              
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
            </div>
            <div class="md-footer__title">
              <span class="md-footer__direction">
                Previous
              </span>
              <div class="md-ellipsis">
                hiv
              </div>
            </div>
          </a>
        
        
          
          <a href="../../../reading/" class="md-footer__link md-footer__link--next" aria-label="Next: reading">
            <div class="md-footer__title">
              <span class="md-footer__direction">
                Next
              </span>
              <div class="md-ellipsis">
                reading
              </div>
            </div>
            <div class="md-footer__button md-icon">
              
              <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M4 11v2h12l-5.5 5.5 1.42 1.42L19.84 12l-7.92-7.92L10.5 5.5 16 11H4Z"/></svg>
            </div>
          </a>
        
      </nav>
    
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "../../../..", "features": ["navigation.path", "navigation.footer"], "search": "../../../../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    
      <script src="../../../../assets/javascripts/bundle.af256bd8.min.js"></script>
      
        <script src="../../../../js/timeago.min.js"></script>
      
        <script src="../../../../js/timeago_mkdocs_material.js"></script>
      
        <script src="../../../../javascripts/mathjax.js"></script>
      
        <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
      
        <script src="https://cdn.jsdelivr.net/gh/ObsidianPublisher/assets@main/dist/javascript.js"></script>
      
    
  </body>
</html>